Johns Hopkins Medicine: Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma
November 19, 2025
November 19, 2025
BALTIMORE, Maryland, Nov. 19 (TNSjou) -- Johns Hopkins Medicine issued the following news release:
* * *
Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of treatment.
Results from the phase 2 clinical trial (NCT03521830), . . .
* * *
Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of treatment.
Results from the phase 2 clinical trial (NCT03521830), . . .